Zu "155270-99-8" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Istradefylline
Artikelnummer: TGM-T6552-100mg
Description: Istradefylline (KW-6002)(Ki of 2.2 nM) is a selective adenosine A2A receptor (A2AR) antagonist, which is under development in Phase 3 trails. It has been used in trials studying the treatment and basic science of Drug Abuse, Sleep Disorder, Hepatic Impairment, Parkinson's Disease, and Restless Legs...
| Schlagworte: | KW-6002 |
| Anwendung: | Targets adenosine receptor A2a (ADORA2A, ADOR) |
| CAS | 155270-99-8 |
| MW: | 384.43 D |
ab 37,00 €
Istradefylline
Artikelnummer: LKT-I7478.25
Istradefylline is a competitive inhibitor of adenosine A2A receptors that exhibits tremorlytic activity. Istradefylline is currently under examination as a potential treatment for Parkinson's disease, as it decreases "off" time in subjects with Parkinson's disease without worsening dyskinesia. Istradefylline...
| Schlagworte: | 8-[(1E)-2-(3,4-Dimethoxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-1H-purine-2,6-dione, KW-6002 |
| Anwendung: | Adenosine A2a receptor antagonist |
| CAS | 155270-99-8 |
| MW: | 384.43 D |
ab 126,00 €
Istradefylline
Artikelnummer: Cay22958-10
Istradefylline is an adenosine receptor 2A (A2A) antagonist (Ki = 2.2 nM in a radioligand binding assay). In vivo, istradefylline inhibits catalepsy induced by haloperidol (Cay-12014) with an ED50 value of 0.23 mg/kg in rats. Oral administration of istradefylline alleviates postural defects in a dose-dependent...
| Schlagworte: | KW 6002, 8-[(1E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-1H-purine-2,6-dione |
| Anwendung: | Adenosine A2A receptor antagonist |
| CAS | 155270-99-8 |
| MW: | 384.4 D |
ab 166,00 €
